Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended on June 30, 2025
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has submitted to the stock exchanges copies of its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) as published in the newspapers Financial Express and Jansatta on August 1, 2025. This filing is being made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The actual quarterly numbers themselves are not clearly readable in the provided text, but the document represents a routine regulatory compliance step rather than new financial information. The signed letter was submitted by Hitesh Kumar Jain, Company Secretary and Compliance Officer.
This is a procedural compliance filing and does not contain new information beyond what was already disclosed when the results were originally announced. Shareholders and investors should refer to the earlier results announcement for the actual Q1 FY26 numbers. No new material impact on stock price is expected from this disclosure itself.